Cardax Inc.’s revenue jumped 71 percent in the third quarter as sales of its new anti-inflammatory product remained strong in Hawaii and accelerated in California, Nevada and New York. Read more
Mahalo for reading the Honolulu Star-Advertiser!
You're reading a premium story. Read the full story with our Print & Digital Subscription.Subscribe Now